| Market Cap | ₹2,540Cr |
| ROE | 0.51% |
| P/E Ratio(TTM) | 323.25 |
| EPS(TTM) | 1.77 |
| P/B Ratio | 1.66 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.07 |
| Book Value | 344.59 |
| Debt to Equity | 0.51 |
| Face Value | 10 |
| Parent Organisation | Solara Active Pharma Sciences Limited |
| Managing Director | Mr. Poorvank Purohit |
| Founded | 2017 |
| NSE Symbol | SOLARA |
| FUND NAME | AUM(%) |
|---|---|
| Aditya Birla Sun Life Flexi Cap Fund Direct Growth | 0.09% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.27 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.05 | ||
| Wockhardt | NA (0.00%) | -449.22 | ||
| Cohance Lifesciences | NA (0.00%) | 65.70 |